144 related articles for article (PubMed ID: 36577396)
1. OnabotulinumtoxinA Injections for the Treatment of Myofascial Pelvic Pain: 12-Year Experience at a Tertiary Care Academic Center.
Lewis GK; Carrubba AR; Stanton AP; Craver EC; Li Z; Chen AH
Gynecol Obstet Invest; 2023; 88(1):37-46. PubMed ID: 36577396
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.
Dessie SG; Von Bargen E; Hacker MR; Haviland MJ; Elkadry E
Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522
[TBL] [Abstract][Full Text] [Related]
3. Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain.
Halder GE; Scott L; Wyman A; Mora N; Miladinovic B; Bassaly R; Hoyte L
Investig Clin Urol; 2017 Mar; 58(2):134-139. PubMed ID: 28261683
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
Adelowo A; Hacker MR; Shapiro A; Modest AM; Elkadry E
Female Pelvic Med Reconstr Surg; 2013; 19(5):288-92. PubMed ID: 23982578
[TBL] [Abstract][Full Text] [Related]
5. Role of 3 Tesla MR Neurography and CT-guided Injections for Pudendal Neuralgia: Analysis of Pain Response.
Ly J; Scott K; Xi Y; Ashikyan O; Chhabra A
Pain Physician; 2019 Jul; 22(4):E333-E344. PubMed ID: 31337177
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
Morrissey D; El-Khawand D; Ginzburg N; Wehbe S; O'Hare P; Whitmore K
Female Pelvic Med Reconstr Surg; 2015; 21(5):277-82. PubMed ID: 25900057
[TBL] [Abstract][Full Text] [Related]
7. Measuring the Quality of Pudendal Nerve Perineural Injections.
Antolak S; Antolak C; Lendway L
Pain Physician; 2016 May; 19(4):299-306. PubMed ID: 27228517
[TBL] [Abstract][Full Text] [Related]
8. Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study.
Anderson CC; Iser CR; Hirte IL; Boddu S; Girardo ME; VanderPluym JH; Starling AJ
Headache; 2024 Jun; 64(6):663-673. PubMed ID: 38700250
[TBL] [Abstract][Full Text] [Related]
9. Botulinum injections for myofascial pelvic pain.
Jha S; Toozs-Hobson P; Roper JC; Gurung S; Brair A; Bach F
Int Urogynecol J; 2021 May; 32(5):1151-1156. PubMed ID: 32696187
[TBL] [Abstract][Full Text] [Related]
10. Methodological approaches to botulinum toxin for the treatment of chronic pelvic pain, vaginismus, and vulvar pain disorders.
Karp BI; Tandon H; Vigil D; Stratton P
Int Urogynecol J; 2019 Jul; 30(7):1071-1081. PubMed ID: 30617506
[TBL] [Abstract][Full Text] [Related]
11. Simplified technique for injection of Botulinum Toxin to Obturator Internus muscle using ultrasound-guided nerve stimulation for persistent pelvic pain.
Evans SF; Porter JM
Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):612-4. PubMed ID: 26224128
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.
Meister MR; Brubaker A; Sutcliffe S; Lowder JL
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e152-e160. PubMed ID: 32301801
[TBL] [Abstract][Full Text] [Related]
13. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
[TBL] [Abstract][Full Text] [Related]
14. Initial experience using a novel nerve stimulator for the management of pudendal neuralgia.
Hoang Roberts L; Vollstedt A; Volin J; McCartney T; Peters KM
Neurourol Urodyn; 2021 Aug; 40(6):1670-1677. PubMed ID: 34196055
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A and myofascial pain syndrome: a retrospective study of 301 patients.
Avendaño-Coy J; Gómez-Soriano J; Valencia M; Estrada J; Leal F; Ruiz-Campa R
J Back Musculoskelet Rehabil; 2014; 27(4):485-92. PubMed ID: 24867895
[TBL] [Abstract][Full Text] [Related]
16. The prediction and treatment of postpartum myofascial pelvic pain.
Zheng YY; Ni LY; Ni FF; Wang XQ; Chen YM; Guo M; Dong XX; Pan QH; Chen C
Technol Health Care; 2023; 31(2):593-605. PubMed ID: 36314230
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of botulinum toxin a injections in pelvic floor muscles in chronic pelvic pain patients: a systematic review and meta-analysis.
Spruijt MA; Klerkx WM; Kelder JC; Kluivers KB; Kerkhof MH
Int Urogynecol J; 2022 Nov; 33(11):2951-2961. PubMed ID: 35362767
[TBL] [Abstract][Full Text] [Related]
18. Committee opinion: onabotulinumtoxinA and the bladder.
American Urogynecologic Society and American College of Obstetricians and Gynecologists
Female Pelvic Med Reconstr Surg; 2014; 20(5):245-7. PubMed ID: 25181372
[TBL] [Abstract][Full Text] [Related]
19. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
[TBL] [Abstract][Full Text] [Related]
20. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
Ojala T; Arokoski JP; Partanen J
Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
